Key facts
- MyLaurel’s last known valuation is $354.0M (Aug 2020).
- It has raised $122.3M; the latest was Later Stage VC ($12.0M) in Nov 2025.
- Notable investors include GV, Founders Fund, City Light Capital, MaC Venture Capital, Emerson Collective — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for MyLaurel
- ·The full record, as it builds
Funding rounds
No funding rounds for MyLaurel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MyLaurel
Provider of on-demand medical care services intended to cater to the needs of frail and complex patients. The company offers in-home ultrasound and other related services through Bluetooth devices that transmit patient vitals to emergency physicians and provide a wide range of medications, helping patients with medical care in case of emergency.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 70
- Website
- mylaurelhealth.com/
- Ownership
- Privately Held (backing)
MyLaurel doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MyLaurel shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MyLaurel in its N-PORT filings yet. We sweep new filings monthly.